Catalyst
Slingshot members are tracking this event:
European Medicines Agency Adopts Positive Opinion Recommending Kite Pharma's (KITE) KTE-C19 for Orphan Treatment Designation for Advanced Hematological Cancers
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 15, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ema, Kte-c19, Orphan Treatment Designation, Advanced Hematological Cancers, True Human Antibody Technology
